Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Renal Function in Patient with Heart Failure

Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor is a recently introduced oral agent to treat renal anemia, but its clinical implications on renal functioning in patients with heart failure remains unknown. We studied an 81-year-old man with heart failure with mildly reduced ejection f...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Ueno, Yohei, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704914/
https://www.ncbi.nlm.nih.gov/pubmed/34940544
http://dx.doi.org/10.3390/jcdd8120189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704914/
https://www.ncbi.nlm.nih.gov/pubmed/34940544
http://dx.doi.org/10.3390/jcdd8120189

Ejemplares similares